METRNL Response, Plasma Oxidative and Antioxidant Indices to HIIT and Aloe Vera Supplementation in Patients With Diabetes Type 2
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 44
- 试验地点
- 2
- 主要终点
- METRNL - Meteorin Like, Glial Cell Differentiation Regulator
研究概览
简要总结
Diabetes is a prevalent metabolic disease that leads to increased blood sugar levels due to insulin shortage or resistance. Type 2 diabetes is often linked to obesity, which can increase insulin resistance. Meteorin-like protein (METRNL) is a new secreted protein that affects insulin sensitivity and has been found to be negatively related to serum glucose levels in people with diabetes.
Oxidative stress in diabetics can stimulate the production of inflammatory mediators, increasing the activity of the antioxidant system. Aloe vera, a widely used plant, has been used for treating diabetes, wound healing, tumors, and inflammatory bowel disease. It has anti-inflammatory, antioxidant, neuroprotective, antidepressant, and memory-enhancing effects.
Exercise can improve diabetic patients' conditions by increasing the expression of GLUT4 protein and skeletal muscle. High-intensity interval training has been shown to increase the expression of the METORIN gene in human subjects and decrease MDA in type 2 diabetic patients. However, no studies have examined the simultaneous effect of exercise and Aloe vera on diabetes indicators.
The present study aims to investigate the response of METRNL and some oxidative and antioxidant plasma indicators to high-intensity interval training and Aloe vera supplementation in type 2 diabetic men. The findings indicate that exercise and consumption of plants with anti-inflammatory and antioxidant properties can be effective in modulating the pathological effects of diabetes and increasing insulin sensitivity.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Outcomes Assessor)
盲法说明
The participants were blinded for the supplementation.
入排标准
- 年龄范围
- 25 Years 至 40 Years(Adult)
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •Male participants who have been diagnosed with T2DM at least 3 months prior to the start of the study according to standard criteria
- •Inactive participants according to the International Physical Activity Questionnaire (IPAQ)
- •Participants receiving stable medical therapy for T2DM, excluding those on exogenous insulin therapy
- •Participants who were free from injuries or chronic health conditions that could limit their ability to safely participate in an intense exercise program were included in the study
排除标准
- •Fasting glucose above 270 mg / dL
- •Exogenous insulin
- •History of diabetic complications (the final stage of proliferative diabetic retinopathy, or subsequent overt nephropathy, diabetic ketoacidosis, or severe diabetic neuropathy)
- •Hereditary glucose and galactose malabsorption
结局指标
主要结局
METRNL - Meteorin Like, Glial Cell Differentiation Regulator
时间窗: Baseline and 12 weeks
Plasma METRNL content was measured using a special kit (Mybiosource company, USA) with a sensitivity of \<0.64 ng / ml, range of 1.56-100 ng / ml by ELISA method
次要结局
- Total antioxidant blood capacity (TAD)(Baseline and 12 weeks)
- Glutathione peroxidase (GPx)(Baseline and 12 weeks)
- Serum superoxide dismutase (SOD)(Baseline and and 12 weeks)
- Plasma malondialdehyde (MDA)(Baseline and 12 weeks)
研究者
Anja Lazić
Junior Researcher
University of Nis
